XML 26 R12.htm IDEA: XBRL DOCUMENT  v2.3.0.11
FAIR VALUE MEASUREMENTS
6 Months Ended
Jun. 30, 2011
FAIR VALUE MEASUREMENTS  
FAIR VALUE MEASUREMENTS

7.     FAIR VALUE MEASUREMENTS

  • Assets and Liabilities Measured at Fair Value on a Recurring Basis

    The following fair value hierarchy table presents the components of the Company's financial assets and liabilities measured at fair value as of June 30, 2011 and December 31, 2010:

   
  As of June 30, 2011   As of December 31, 2010  
   
  Carrying
Value
  Quoted Prices
in Active
Markets for
Identical
Assets
(Level 1)
  Significant
Other
Observable
Inputs
(Level 2)
  Significant
Unobservable
Inputs
(Level 3)
  Carrying
Value
  Quoted Prices
in Active
Markets for
Identical
Assets
(Level 1)
  Significant
Other
Observable
Inputs
(Level 2)
  Significant
Unobservable
Inputs
(Level 3)
 
 

Assets:

                                                 
   

Cash and cash equivalents:

                                                 
     

Money market funds

  $ 59,842   $ 59,842   $   $   $ 91,448   $ 91,448   $   $  
   

Marketable securities:

                                                 
     

Available-for-sale equity securities:

                                                 
       

Sanitas ordinary shares(a)

    9,170     9,170                          
     

Available-for-sale debt securities:

                                                 
       

Corporate bonds

    2,954     2,954             6,340         6,340      
       

Government-sponsored enterprise securities

                    1,826         1,826      
                                     
 

 

  $ 71,966   $ 71,966   $   $   $ 99,614   $ 91,448   $ 8,166   $  
                                     
 

Liabilities:

                                                 
   

Acquisition-related contingent consideration

  $ (420,698 ) $   $   $ (420,698 ) $ (20,220 ) $   $   $ (20,220 )

(a)
In June 2011, in connection with an agreement to acquire AB Sanitas ("Sanitas"), as described in note 20, the Company invested $9.2 million to acquire 660,891 ordinary shares of Sanitas, which represented approximately 2.0% of the outstanding share capital of Sanitas.
  • Fair value measurements are estimated based on valuation techniques and inputs categorized as follows:

    Level 1 — Quoted prices (unadjusted) for identical securities in active markets.

    Level 2 — Quoted prices (unadjusted) for identical securities in markets that are not active.

    Level 3 — Discounted cash flow method (income approach) using significant inputs not observable in the market.
  • The fair value measurement of contingent consideration obligations arising from business combinations is determined using unobservable (Level 3) inputs. These inputs include (i) the estimated amount and timing of projected cash flows; (ii) the probability of the achievement of the factor(s) on which the contingency is based; and (iii) the risk-adjusted discount rate used to present value the probability-weighted cash flows. The following table presents a reconciliation of contingent consideration obligations measured on a recurring basis for the six months ended June 30, 2011:

   
  Balance,
January 1,
2011
  Issuances   Net
Unrealized
Loss
(Gain)(a)
  Foreign
Exchange(b)
  Transfers
Into Level 3
  Transfers
Out of Level 3
  Balance,
June 30,
2011
 
 

Acquisition-related contingent consideration

    20,220     397,150     2,138     1,190             420,698  

(a)
Recognized as acquisition-related contingent consideration in the consolidated statements of income.

(b)
Included in foreign exchange and other in the consolidated statements of income.
  • Assets and Liabilities Measured at Fair Value on a Non-Recurring Basis

    There were no significant assets or liabilities that were re-measured at fair value on a non-recurring basis subsequent to initial recognition in the six months ended June 30, 2011.